Workflow
Axsome Therapeutics, Inc. (AXSM) Presents at TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Transcript
Seeking Alpha· 2025-09-18 05:53
Everyone, good morning, and thank you for joining us for our Fifth Annual TD Cowen Novel Mechanisms in Neuropsychiatry and Epilepsy Summit. I'm Joe Thome, one of the senior biotech analysts here on the team at TD Cowen, and it is my pleasure to kick things off this morning with the team from Axsome Therapeutics. And joining me today, we have COO, Mark Jacobson; and CFO, Nick Pizzie. So thanks, guys, for joining us this morning.Question-and-Answer Session Joseph ThomeTD Cowen, Research Division Maybe just a ...
Zoom Communications Inc. - Special Call
Seeking Alpha· 2025-09-18 05:53
PresentationCharles EveslageHead of Investor Relations Thank you, Annabeth. We're excited to host you all for another Zoomtopia and hope you're able to catch the keynote and other content earlier today. And here's our agenda: First, Michelle will take us through a short presentation highlighting vision priorities, our execution towards the top line and also towards shareholder returns and framing the news of today for this financially focused audience. Then Michelle will be joined by Eric, our CEO, Kim Stor ...
Broadcom Shares Spike After Hours On Lloyds Partnership Buzz, Director Sells $288,000 Worth Of Stock - Broadcom (NASDAQ:AVGO)
Benzinga· 2025-09-18 05:45
Broadcom Inc. AVGO shares are trending on Thursday.Check out the current price of AVGO stock here. Pre-Market Movement Shows Continued StrengthThe stock of the Californian company gained 1.31% in after-hours trading to $350.70, adding $4.53 to its Wednesday closing price of $346.17. According to Benzinga Pro data, Broadcom Inc. closed regular trading down 3.84% but recovered in extended hours following news of strategic partnerships and continued AI sector momentum.See Also: Nvidia Rival Groq Raises $750 Mi ...
Meta Platforms, Inc. (META) Presents at Connect 2025 Transcript
Seeking Alpha· 2025-09-18 05:33
PresentationMark ZuckerbergFounder, Chairman & CEO Thank you. We'll talk about these in a minute. Welcome to Connect. All right. AI glasses and Virtual Reality. Our goal is to build great-looking glasses that deliver personal super intelligence and a feeling of presence using realistic holograms, and these ideas combined to what we call the Metaverse. Now glasses are the ideal form factor for personal super intelligence because they let you stay present in the moment, while getting access to all of these A ...
'Just a joy': Margot Robbie and Colin Farrell on their movie A Big Bold Beautiful Journey
Abc.Net.Au· 2025-09-18 05:33
Margot Robbie and Colin Farrell walk through a mystical door to relive defining moments from their pasts in their new movie A Big Bold Beautiful Journey.  "It is a love story between David (Colin Farrell) and Sarah (Margot Robbie), but it is also about loving yourself before you can love someone else," Robbie says. Sarah (Margot Robbie) and David (Colin Farrell) in A Big Bold Beautiful Journey. (Supplied / Sony Pictures)The characters go back to the past to see how they got to where they are in the present. ...
Spirit Airlines To Cut Jobs As It Plans To Reduce Capacity By 25% Amid Financial Woes: Report - Spirit Aviation Holdings (OTC:FLYYQ)
Benzinga· 2025-09-18 05:32
Budget flight carrier Spirit Aviation Holdings Inc. FLYYQ is reportedly planning to reduce its workforce and cut capacity by over 25% YoY amid ongoing financial woes.A Shift To Focus On Spirit's Strongest MarketsThe reduction comes as CEO Dave Davis, in an internal document obtained by CNBC on Wednesday, said that the company will cut capacity to focus on the airline's strongest markets. "These evaluations will inevitably affect the size of our teams as we become a more efficient airline," Davis said in the ...
Sampo plc’s share buybacks 17 September 2025
Globenewswire· 2025-09-18 05:30
Sampo plc, stock exchange release, 18 September 2025 at 8:30 am EEST Sampo plc’s share buybacks 17 September 2025 On 17 September 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows: Sampo plc’s share buybacksAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares*Market (MIC Code) 5,8249.81AQEU 113,3529.81CEUX 32,1619.81TQEX 177,3199.81<td style="width: ...
Implementation of a share buyback program
Globenewswire· 2025-09-18 05:30
IMPLEMENTATION OF A SHARE BUYBACK PROGRAM Saint-Ouen, 18 September 2025, 7:30 a.m. (CET) Nexity announces the implementation of a share buyback program, pursuant to the authorization granted at the Shareholders’ General Meeting held on 22 May 2025. The buyback mandate covers a maximum of 200,000 shares. These shares will be fully allocated to cover free share plans, particularly in the context of employee share ownership schemes. NEXITY, LIFE TOGETHERWith €3.5 billion in revenue in 2024, Nexity has a natio ...
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Globenewswire· 2025-09-18 05:30
Detailed results from clinical feasibility studies show immediate improvement in blood pressure stability and durable reduction of hypotensive symptoms, resulting in improved quality of life Most people living with spinal cord injury experience blood pressure instability, which represents a key unmet needToday’s concurrent publications provide clinical evidence for ARC-IM® Therapy ahead of the Company’s planned initiation of the Empower BP global pivotal trial later this year EINDHOVEN, The Netherlands, Sep ...
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Globenewswire· 2025-09-18 05:30
Detailed results from clinical feasibility studies show immediate improvement in blood pressure stability and durable reduction of hypotensive symptoms, resulting in improved quality of life Most people living with spinal cord injury experience blood pressure instability, which represents a key unmet needToday’s concurrent publications provide clinical evidence for ARC-IM® Therapy ahead of the Company’s planned initiation of the Empower BP global pivotal trial later this year EINDHOVEN, The Netherlands, Sep ...